Cognitive and psychological characteristics in patients with Cerebral Amyloid Angiopathy: a literature review.
Cerebral amyloid angiopathy
Cognitive factors
Evaluation
Psychological factors
Journal
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
ISSN: 1590-3478
Titre abrégé: Neurol Sci
Pays: Italy
ID NLM: 100959175
Informations de publication
Date de publication:
22 Feb 2024
22 Feb 2024
Historique:
received:
11
09
2023
accepted:
08
02
2024
medline:
23
2
2024
pubmed:
23
2
2024
entrez:
22
2
2024
Statut:
aheadofprint
Résumé
To review the current data on cognitive and psychological characteristics of patients with CAA and on the instruments used for their evaluation. A systematic search was performed in Embase, Scopus and PubMed with terms related to "cerebral amyloid angiopathy", "neuropsychological measures" and "patient-reported outcome measures" from January 2001 to December 2021. Out of 2851 records, 18 articles were selected. The cognitive evaluation was present in all of which, while the psychological one only in five articles. The MMSE (Mini Mental State Examination), TMT (Trail Making Test), fluency test, verbal learning test, digit span, digit symbol and Rey figure tests were the most used cognitive tests, while executive function, memory, processing speed, visuospatial function, attention and language were the most frequent impaired cognitive functions. Depression was the most considered psychological factor usually measured with BDI (Beck Depression Inventory) and GDS (Geriatric Depression Scale). The results of this study might be used in clinical practice as a guide to choose cognitive and psychological instruments and integrate them in the clinical evaluation. The results might also be used in the research field for studies investigating the impact of cognitive and psychological variables on the disease course and for consensus studies aimed at define a standardized evaluation of these aspects.
Identifiants
pubmed: 38388894
doi: 10.1007/s10072-024-07399-7
pii: 10.1007/s10072-024-07399-7
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. Fondazione Società Italiana di Neurologia.
Références
Revesz T et al (2003) Cerebral amyloid angiopathies: A pathologic, biochemical, and genetic view. J Neuropathol Exp Neurol 62(9):885–898. https://doi.org/10.1093/jnen/62.9.885
doi: 10.1093/jnen/62.9.885
pubmed: 14533778
Van Etten ES et al (2016) Recurrent hemorrhage risk and mortality in hereditary and sporadic cerebral amyloid angiopathy. Neurology 87(14):1482–1487. https://doi.org/10.1212/WNL.0000000000003181
doi: 10.1212/WNL.0000000000003181
pubmed: 27590282
pmcid: 5075977
Viswanathan A, Greenberg SM (2011) Cerebral amyloid angiopathy in the elderly. Ann Neurol 70(6):871–880. https://doi.org/10.1002/ana.22516
doi: 10.1002/ana.22516
pubmed: 22190361
pmcid: 4004372
Greenberg SM, Charidimou A (2018) Diagnosis of cerebral amyloid angiopathy evolution of the Boston criteria. Stroke 49(2):491–497. https://doi.org/10.1161/STROKEAHA.117.016990
doi: 10.1161/STROKEAHA.117.016990
pubmed: 29335334
pmcid: 5892842
Charidimou A et al (2022) The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI–neuropathology diagnostic accuracy study. Lancet Neurol 21(8):714–725. https://doi.org/10.1016/S1474-4422(22)00208-3
doi: 10.1016/S1474-4422(22)00208-3
pubmed: 35841910
pmcid: 9389452
Lovelock C, Molyneux A, Rothwell P (2007) Change in incidence and aetiology of intracerebral haemorrhage in Oxfordshire, UK, between 1981 and 2006: a population-based study. Lancet Neurol 6(6):487–493. https://doi.org/10.1016/S1474-4422(07)70107-2
doi: 10.1016/S1474-4422(07)70107-2
pubmed: 17509483
Theodorou A et al (2023) Clinical, Neuroimaging, and Genetic Markers in Cerebral Amyloid Angiopathy-Related Inflammation: A Systematic Review and Meta-Analysis. Stroke 54(1):178–188. https://doi.org/10.1161/STROKEAHA.122.040671
doi: 10.1161/STROKEAHA.122.040671
pubmed: 36453271
Malhotra K et al (2022) Prevalence of Clinical and Neuroimaging Markers in Cerebral Amyloid Angiopathy: A Systematic Review and Meta-Analysis. Stroke 53(6):1944–1953. https://doi.org/10.1161/STROKEAHA.121.035836
doi: 10.1161/STROKEAHA.121.035836
pubmed: 35264008
Schrag M et al (2010) Correlation of hypointensities in susceptibility-weighted images to tissue histology in dementia patients with cerebral amyloid angiopathy: A postmortem MRI study. Acta Neuropathol 119(3):291–302. https://doi.org/10.1007/s00401-009-0615-z
doi: 10.1007/s00401-009-0615-z
pubmed: 19937043
pmcid: 2916065
Linn J et al (2010) Prevalence of superficial siderosis in patients with cerebral amyloid angiopathy. Neurology 74(17):1346–1350. https://doi.org/10.1212/WNL.0b013e3181dad605
doi: 10.1212/WNL.0b013e3181dad605
pubmed: 20421578
pmcid: 2875936
Auriel E et al (2014) Microinfarct disruption of white matter structure: A longitudinal diffusion tensor analysis. Neurology 83(2):182–188. https://doi.org/10.1212/WNL.0000000000000579
doi: 10.1212/WNL.0000000000000579
pubmed: 24920857
pmcid: 4117171
Wermer MJH, Greenberg SM (2018) The growing clinical spectrum of cerebral amyloid angiopathy. Curr Opin Neurol 31(1):28–35. https://doi.org/10.1097/WCO.0000000000000510
doi: 10.1097/WCO.0000000000000510
pubmed: 29120920
Boyle PA et al (2015) Cerebral amyloid angiopathy and cognitive outcomes in community-based older persons. Neurology 85(22):1930–1936. https://doi.org/10.1212/WNL.0000000000002175
doi: 10.1212/WNL.0000000000002175
pubmed: 26537052
pmcid: 4664125
Arvanitakis Z, Leurgans SE, Wang Z, Wilson RS, Bennett DA, Schneider JA (2011) Cerebral amyloid angiopathy pathology and cognitive domains in older persons. Ann Neurol 69(2):320–327. https://doi.org/10.1002/ana.22112
doi: 10.1002/ana.22112
pubmed: 21387377
David ND, Lin F (2016) Trajectories of neuropsychiatric symptoms and cognitive decline in mild cognitive impairment. Am J Geriatr Psychiatry 24(1):70–80. https://doi.org/10.1016/j.jagp.2015.06.001
doi: 10.1016/j.jagp.2015.06.001
pubmed: 26525995
Wadsworth LP, Lorius N, Donovan NJ, Locascio JJ, Rentz DM, Johnson KA, Sperling RA (2012) Neuropsychiatric symptoms and global functional impairment along the Alzheimer’s continuum. Dement Geriatr Cogn Disord 34(2):96–111. https://doi.org/10.1159/000342119
doi: 10.1159/000342119
pubmed: 22922821
Gahr M, Nowak DA, Connemann BJ, Schönfeldt-Lecuona C (2013) Cerebral amyloidal angiopathy - A disease with implications for neurology and psychiatry. Brain Res 1519:19–30. https://doi.org/10.1016/j.brainres.2013.04.052
doi: 10.1016/j.brainres.2013.04.052
pubmed: 23651976
Gleason A, Hayhow B, Emmanuel J, Gaillard F (2014) Cerebral amyloid angiopathy presenting with neuropsychiatric symptoms. Aust N Z J Psychiatry 48(8):779–780. https://doi.org/10.1177/0004867414525843
doi: 10.1177/0004867414525843
pubmed: 24563197
Costa AS, Pinho J, Kučikienė D, Reich A, Schulz JB, Reetz K (2021) Cerebral Amyloid Angiopathy in Amyloid-Positive Patients from a Memory Clinic Cohort. J Alzheimer’s Dis 79(4):1661–1672. https://doi.org/10.3233/JAD-201218
doi: 10.3233/JAD-201218
Su Y, Fu J, Zhang Y, Xu J, Dong Q, Cheng X (2021) Visuospatial dysfunction is associated with posterior distribution of white matter damage in non-demented cerebral amyloid angiopathy. Eur J Neurol 28(9):3113–3120. https://doi.org/10.1111/ene.14993
doi: 10.1111/ene.14993
pubmed: 34157199
Raposo N et al (2021) Peak width of skeletonized mean diffusivity as neuroimaging biomarker in cerebral amyloid angiopathy. Am J Neuroradiol 42(5):875–881. https://doi.org/10.3174/AJNR.A7042
doi: 10.3174/AJNR.A7042
pubmed: 33664113
pmcid: 8115367
Jang YK et al (2017) Distinctive Clinical Effects of Haemorrhagic Markers in Cerebral Amyloid Angiopathy. Sci Rep 7(1):1–8. https://doi.org/10.1038/s41598-017-16298-1
doi: 10.1038/s41598-017-16298-1
Alber J et al (2021) The relationship between cerebral and retinal microbleeds in cerebral amyloid angiopathy (CAA): A pilot study. J Neurol Sci 423(Marc):117383. https://doi.org/10.1016/j.jns.2021.117383
doi: 10.1016/j.jns.2021.117383
pubmed: 33684655
Jang H et al (2019) Clinical significance of amyloid β positivity in patients with probable cerebral amyloid angiopathy markers. Eur J Nucl Med Mol Imaging 46(6):1287–1298. https://doi.org/10.1007/s00259-019-04314-7
doi: 10.1007/s00259-019-04314-7
pubmed: 30937462
McCreary CR et al (2020) Cross-sectional and longitudinal differences in peak skeletonized white matter mean diffusivity in cerebral amyloid angiopathy. NeuroImage Clin 27(September 2019):102280. https://doi.org/10.1016/j.nicl.2020.102280
doi: 10.1016/j.nicl.2020.102280
pubmed: 32521475
pmcid: 7284130
Xiong L et al (2016) Cognitive Profile and its Association with Neuroimaging Markers of Non-Demented Cerebral Amyloid Angiopathy Patients in a Stroke Unit. J Alzheimer’s Dis 52(1):171–178. https://doi.org/10.3233/JAD-150890
doi: 10.3233/JAD-150890
Case NF et al (2016) Cerebral Amyloid Angiopathy is Associated with Executive Dysfunction and Mild Cognitive Impairment. Stroke 47(8):2010–2016. https://doi.org/10.1161/STROKEAHA.116.012999
doi: 10.1161/STROKEAHA.116.012999
pubmed: 27338926
Van Den Brink H et al (2018) Cortical microinfarcts on 3T magnetic resonance imaging in cerebral amyloid angiopathy relations with other magnetic resonance imaging markers of cerebral amyloid angiopathy and cognition. Stroke 49(8):1899–1905. https://doi.org/10.1161/STROKEAHA.118.020810
doi: 10.1161/STROKEAHA.118.020810
pubmed: 29986931
Valenti R et al (2017) Visuospatial Functioning in Cerebral Amyloid Angiopathy: A Pilot Study. J Alzheimer’s Dis 56(4):1223–1227. https://doi.org/10.3233/JAD-160927
doi: 10.3233/JAD-160927
Reijmer YD et al (2015) Structural network alterations and neurological dysfunction in cerebral amyloid angiopathy. Brain 138(1):179–188. https://doi.org/10.1093/brain/awu316
doi: 10.1093/brain/awu316
pubmed: 25367025
Schoemaker D et al (2021) Association of Memory Impairment With Concomitant Tau Pathology in Patients With Cerebral Amyloid Angiopathy. Neurology 96(15):e1975–e1986. https://doi.org/10.1212/WNL.0000000000011745
doi: 10.1212/WNL.0000000000011745
pubmed: 33627498
pmcid: 8166424
Smith EE et al (2021) Cerebral amyloid angiopathy is associated with emotional dysregulation, impulse dyscontrol, and apathy. J Am Heart Assoc 10(22):1–9. https://doi.org/10.1161/JAHA.121.022089
doi: 10.1161/JAHA.121.022089
Planton M et al (2017) High prevalence of cognitive impairment after intracerebral hemorrhage. PLoS ONE 12(6):1–13. https://doi.org/10.1371/journal.pone.0178886
doi: 10.1371/journal.pone.0178886
Xiong L et al (2018) Cerebral cortical microinfarcts on magnetic resonance imaging and their association with cognition in cerebral amyloid angiopathy. Stroke 49(10):2330–2336. https://doi.org/10.1161/STROKEAHA.118.022280
doi: 10.1161/STROKEAHA.118.022280
pubmed: 30355109
pmcid: 6209124
Sreedharan S, Thomas B, Sylaja P, Sarma S (2020) Cerebral Amyloid Angiopathy: A Clinico-Radiological Study from South India. Neurol India 68(2):378–382. https://doi.org/10.4103/0028-3886.280646
doi: 10.4103/0028-3886.280646
pubmed: 32189707
Matsuda K et al (2021) Investigation of hypertensive arteriopathy-related and cerebral amyloid angiopathy-related small vessel disease scores in patients from a memory clinic: A prospective single-centre study. BMJ Open 11(4):042550. https://doi.org/10.1136/bmjopen-2020-042550
doi: 10.1136/bmjopen-2020-042550
Attems J, Jellinger KA, Lintner F (2005) Alzheimer’s disease pathology influences severity and topographical distribution of cerebral amyloid angiopathy. Acta Neuropathol 110(3):222–231. https://doi.org/10.1007/s00401-005-1064-y
doi: 10.1007/s00401-005-1064-y
pubmed: 16133541
Ghafar MZAA, Miptah HN, O’Caoimh R (2019) Cognitive screening instruments to identify vascular cognitive impairment: A systematic review. Int J Geriatr Psychiatry 34(8):1114–1127. https://doi.org/10.1002/gps.5136
doi: 10.1002/gps.5136
pubmed: 31050033
Firbank MJ et al (2012) Relationship between progression of brain white matter changes and late-life depression: 3-Year results from the LADIS study. Br J Psychiatry 201(1):40–45. https://doi.org/10.1192/bjp.bp.111.098897
doi: 10.1192/bjp.bp.111.098897
pubmed: 22626634
Herrmann LL, Le Masurier M, Ebmeier KP (2008) White matter hyperintensities in late life depression: A systematic review. J Neurol Neurosurg Psychiatry 79(6):619–624. https://doi.org/10.1136/jnnp.2007.124651
doi: 10.1136/jnnp.2007.124651
pubmed: 17717021
Enache D, Winblad B, Aarsland D (2011) Depression in dementia: Epidemiology, mechanisms, and treatment. Curr Opin Psychiatry 24(6):461–472. https://doi.org/10.1097/YCO.0b013e32834bb9d4
doi: 10.1097/YCO.0b013e32834bb9d4
pubmed: 21926624
Reijnders JSAM, Ehrt U, Weber WEJ, Aarsland D, Leentjens AFG (2008) A systematic review of prevalence studies of depression in Parkinson’s disease. Mov Disord 23(2):183–189. https://doi.org/10.1002/mds.21803
doi: 10.1002/mds.21803
pubmed: 17987654
Tay KW, Subramaniam P, Oei TP (2019) Cognitive behavioural therapy can be effective in treating anxiety and depression in persons with dementia: a systematic review. Psychogeriatrics 19(3):264–275. https://doi.org/10.1111/psyg.12391
doi: 10.1111/psyg.12391
pubmed: 30548731